The following pages contain information relating to a proposed transaction by Ascelia Pharma AB. This information may not be accessed by residents of certain countries based on applicable securities law regulations.
From the menu please choose the country where you reside:
Where do you reside? Sweden Member State of the European Economic Area Australia Canada Japan New Zealand South Africa USA Other country
From the menu please choose the country in which you are currently physically present:
Where are you currently physically present? Sweden Member State of the European Economic Area Australia Canada Japan New Zealand South Africa USA Other country
The information contained in this section of the website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”), Australia, Canada, Japan or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.
The following pages contain information relating to an initial public offering and listing of securities issued by Ascelia Pharma AB (the
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN
The following pages include information pertaining to an initial public offering and listing of securities issued by the Company.
This website and the information contained herein are not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”), Australia, Canada or Japan, and do not constitute an offer to sell or the solicitation of an offer to
All persons residing outside of the United States, Australia, Canada and Japan who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this website.
Access to electronic versions of these materials is being made available on this website by the Company in good faith and for
By clicking “Yes” you confirm and certify that:
You are not a resident of or physically present in the United States, Australia, Canada or Japan or any other restricted jurisdiction and are not a U.S. person (as defined in Regulation S under the U.S. Securities Act); and you are either: (a) a resident of, or physically present in, Sweden; (b) if resident or physically present in a Member State of the European Economic Area other than Sweden, a qualified investor as defined in Directive 2003/71/EC (as amended); or (c) otherwise authorised to access this information pursuant to applicable laws or regulations.
